Literature DB >> 9291445

Frequency of sudden cardiac death and profiles of risk.

R J Myerburg1, A Interian, R M Mitrani, K M Kessler, A Castellanos.   

Abstract

The epidemiology of ventricular tachycardia/fibrillation (VT/VF) and sudden cardiac death (SCD) must be explored from multiple aspects, each of which contributes insights into the problem and no one of which exerts exclusive dominance for preventive or therapeutic strategies. These include: (1) population dynamics, using conventional epidemiologic approaches; (2) risk as a function of time from an index event; (3) conditioning risk factors, based on the presence of underlying disease states; (4) transient risk factors that are dynamic and trigger a potentially fatal event at a specific point in time; and (5) "response risk," which refers to individual susceptibility (possibly determined genetically) to the adverse effects of longitudinal and/or dynamic risk factors. Major inroads into profiling individual or population risk of SCD will require better understanding of each of these epidemiologic-clinical-physiologic interactions. The disciplines range from epidemiology, through clinical medicine, to membrane channel physiology, genetic determinants, and molecular biology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291445     DOI: 10.1016/s0002-9149(97)00477-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  91 in total

Review 1.  Secondary prevention of sudden death.

Authors:  R Cappato; K H Kuck
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 2.  [Cardiology update. I: Electrophysiology].

Authors:  P Weismüller; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-01-15

3.  Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study.

Authors:  Shani Shastri; Navdeep Tangri; Hocine Tighiouart; Gerald J Beck; Panagiotis Vlagopoulos; Daniel Ornt; Garabed Eknoyan; John W Kusek; Charles Herzog; Alfred K Cheung; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

Review 4.  Drug- and non-drug-associated QT interval prolongation.

Authors:  Charlotte van Noord; Mark Eijgelsheim; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

5.  Cost-effectiveness of in-home automated external defibrillators for individuals at increased risk of sudden cardiac death.

Authors:  Peter Cram; Sandeep Vijan; David Katz; A Mark Fendrick
Journal:  J Gen Intern Med       Date:  2005-03       Impact factor: 5.128

6.  The atherosclerotic plaque: a healthy challenge to the limits of nuclear imaging.

Authors:  Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

7.  Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study.

Authors:  Sumeet S Chugh; Kyndaron Reinier; Tejwant Singh; Audrey Uy-Evanado; Carmen Socoteanu; Dawn Peters; Ronald Mariani; Karen Gunson; Jonathan Jui
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

8.  QT interval and long-term mortality risk in the Framingham Heart Study.

Authors:  Peter A Noseworthy; Gina M Peloso; Shih-Jen Hwang; Martin G Larson; Daniel Levy; Christopher J O'Donnell; Christopher Newton-Cheh
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

9.  Frequency of use of QT-interval prolonging drugs in psychiatry in Belgium.

Authors:  Eline Vandael; Thomas Marynissen; Johan Reyntens; Isabel Spriet; Joris Vandenberghe; Rik Willems; Veerle Foulon
Journal:  Int J Clin Pharm       Date:  2014-05-08

Review 10.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.